Cargando…

Potentiation of the anticancer effects of everolimus using a dual mTORC1/2 inhibitor in hepatocellular carcinoma cells

There is lots of evidence to support the critical involvement of mTOR signaling in the carcinogenesis of hepatocellular carcinoma (HCC). However, it has not been determined how the roles of individual mTORC1 and mTORC2 inhibitors played in the HCC therapeutics. We thus compared the effects of everol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jong-Ok, Kim, Kee-Hwan, Song, In Sang, Cheon, Kwang-Sik, Kim, Ok-Hee, Lee, Sang Chul, Lee, Sang Kuon, Kim, Say-June
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356853/ https://www.ncbi.nlm.nih.gov/pubmed/27935857 http://dx.doi.org/10.18632/oncotarget.13808

Ejemplares similares

Everolimus Plus Ku0063794 Regimen Promotes Anticancer Effects against Hepatocellular Carcinoma Cells through the Paradoxical Inhibition of Autophagy
por: Lee, Sang Chul, et al.
Publicado: (2018)

IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression
por: Lee, Sang Chul, et al.
Publicado: (2015)

HSP90 inhibitor 17-DMAG exerts anticancer effects against gastric cancer cells principally by altering oxidant-antioxidant balance
por: Kim, Jeong Goo, et al.
Publicado: (2017)

Does Korea's current diagnosis-related group-based reimbursement system appropriately classify appendectomy patients?
por: Kim, Kee-Hwan, et al.
Publicado: (2016)

Determination of optimized oxygen partial pressure to maximize the liver regenerative potential of the secretome obtained from adipose-derived stem cells
por: Lee, Sang Chul, et al.
Publicado: (2017)

Combining Everolimus and Ku0063794 Promotes Apoptosis of Hepatocellular Carcinoma Cells via Reduced Autophagy Resulting from Diminished Expression of miR-4790-3p
por: Choi, Ho Joong, et al.
Publicado: (2021)

Lipopolysaccharide preconditioning of adipose-derived stem cells improves liver-regenerating activity of the secretome
por: Lee, Sang Chul, et al.
Publicado: (2015)

The utility of the preoperative neutrophil-to-lymphocyte ratio in predicting severe cholecystitis: a retrospective cohort study
por: Lee, Sang Kuon, et al.
Publicado: (2014)

Inhibition of mTORC1 through ATF4-induced REDD1 and Sestrin2 expression by Metformin
por: Jang, Se-Kyeong, et al.
Publicado: (2021)

Correction to: Inhibition of mTORC1 through ATF4-induced REDD1 and Sestrin2 expression by Metformin
por: Jang, Se-Kyeong, et al.
Publicado: (2021)

mTORC1 accelerates retinal development via the immunoproteasome
por: Choi, Ji-Heon, et al.
Publicado: (2018)

mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016)

SAT-059 Treatment Of Primary Aldosteronism With The mTORC1 Inhibitor Everolimus
por: Trinh, Beckey, et al.
Publicado: (2019)

Enhanced Therapeutic Potential of the Secretome Released from Adipose-Derived Stem Cells by PGC-1α-Driven Upregulation of Mitochondrial Proliferation
por: Lee, Jaeim, et al.
Publicado: (2019)

mTORC1 and mTORC2 are differentially engaged in the development of laser-induced CNV
por: Yang, Jin Young, et al.
Publicado: (2019)

Harnessing adipose-derived stem cells to release specialized secretome for the treatment of hepatitis B
por: Kim, Hee Ju, et al.
Publicado: (2021)

Serum level of visfatin can reflect the severity of inflammation in patients with acute cholecystitis
por: Park, Jae Woo, et al.
Publicado: (2020)

Inhibition of JNK-mediated autophagy enhances NSCLC cell sensitivity to mTORC1/2 inhibitors
por: Jin, Hyeon-Ok, et al.
Publicado: (2016)

A Comparison of Ku0063794, a Dual mTORC1 and mTORC2 Inhibitor, and Temsirolimus in Preclinical Renal Cell Carcinoma Models
por: Zhang, Hao, et al.
Publicado: (2013)

An expanded role for mTORC1 in autophagy
por: Kim, Young-Mi, et al.
Publicado: (2015)

Inhibition of Glutamine Uptake Resensitizes Paclitaxel Resistance in SKOV3-TR Ovarian Cancer Cell via mTORC1/S6K Signaling Pathway
por: Kim, Gyeongmi, et al.
Publicado: (2022)

STAT1 maintains naïve CD8(+) T cell quiescence by suppressing the type I IFN-STAT4-mTORC1 signaling axis
por: Kye, Yoon-Chul, et al.
Publicado: (2021)

A rare collision tumor comprising intracystic papillary neoplasm associated with adenocarcinoma and angiosarcoma in the gallbladder
por: Park, Geon, et al.
Publicado: (2020)

Ameliorating liver fibrosis in an animal model using the secretome released from miR-122-transfected adipose-derived stem cells
por: Kim, Kee-Hwan, et al.
Publicado: (2019)

Differential regulation of mTORC1 by leucine and glutamine
por: Jewell, Jenna L., et al.
Publicado: (2015)

PEBP4 Directs the Malignant Behavior of Hepatocellular Carcinoma Cells via Regulating mTORC1 and mTORC2
por: Chen, Qiongfeng, et al.
Publicado: (2022)

Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines
por: Leung, Euphemia Y., et al.
Publicado: (2015)

Synthetic lethality by targeting the RUVBL1/2-TTT complex in mTORC1-hyperactive cancer cells
por: Shin, Seung Ho, et al.
Publicado: (2020)

Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
por: Tang, Haiyang, et al.
Publicado: (2018)

Hemistepsin a Induces Apoptosis of Hepatocellular Carcinoma Cells by Downregulating STAT3
por: Cho, Il Je, et al.
Publicado: (2021)

Melatonin inhibits glycolysis in hepatocellular carcinoma cells by downregulating mitochondrial respiration and mTORC1 activity
por: Lee, Seunghyeong, et al.
Publicado: (2022)

Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for adult T‐cell leukemia
por: Kawata, Takahito, et al.
Publicado: (2017)

mTORC1/2 inhibitor and curcumin induce apoptosis through lysosomal membrane permeabilization-mediated autophagy
por: Seo, Seung Un, et al.
Publicado: (2018)

Sestrin2 inhibits mTORC1 through modulation of GATOR complexes
por: Kim, Jeong Sig, et al.
Publicado: (2015)

Defects in mTORC1 Network and mTORC1-STAT3 Pathway Crosstalk Contributes to Non-inflammatory Hepatocellular Carcinoma
por: Li, Ting, et al.
Publicado: (2020)

Gene Expression Profiling of Hepatocellular Carcinoma Derived Cancer Stem Like Cell under Hypoxia
por: Choi, Sung Hoon, et al.
Publicado: (2017)

Effectiveness and molecular interactions of the clinically active mTORC1 inhibitor everolimus in combination with tamoxifen or letrozole in vitro and in vivo
por: Martin, Lesley-Ann, et al.
Publicado: (2012)

Dual mTORC1/mTORC2 Inhibition as a Host-Directed Therapeutic Target in Pathologically Distinct Mouse Models of Tuberculosis
por: Tasneen, Rokeya, et al.
Publicado: (2021)

Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion
por: Chen, Long, et al.
Publicado: (2015)

The metabolic waste ammonium regulates mTORC2 and mTORC1 signaling
por: Merhi, Ahmad, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eaq449hp0em4r2foocolrrstig